Zunsemetinib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Zunsemetinib, covering 2026-04-20 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis [Phase 1, Phase 2]